top of page

Panel IV: Business Session

image1 (1).jpeg

Eric Du, MPH, MBA

Lead strategy consultant,
Auriga Advisors

343822606_1989141441438347_3593364653434905695_n_edited.jpg

Chance Lai, MS, MBA

Sr. Director, Product Development

Biomarin Pharmaceutical

  • LinkedIn
Jenny Hsiung.jpg

Jenny Hsiung, MEng, MBA

Associate Director, Business Development & Acquisitions, AbbVie

DSC09609 copy.jpg

Elizabeth Tseng, PhD

Associate Director, Product Marketing, Pacific Biosciences

[Business Panel]

本次活動的Business Panel我們邀請到

Chance Lai - Sr. Director, Product & Portfolio Development at BioMarin

Jenny Hsiung - Associate Director, Business Development & Acquisitions at AbbVie

Elizabeth Tseng - Associate Director, Product Marketing at Pacific Biosciences

Moderator: Eric Du - Lead strategy consultant at Auriga Advisors

面對新藥臨床研究飛速發展,各種AI/ML跨領域的應用,業界不再以傳統方式評估新藥未來上市的潛力。我們將探討業界對於新藥開發的機會點如何評估以及如何佈局投資策略。歡迎加入我們的討論和活動結束後與panelists的networking opportunity!

bottom of page